Navigation Links
Akaza Research to Present OpenClinica Electronic Data Capture Software at Partnerships in Clinical Trials 2010
Date:2/16/2010

Professional open source model demonstrates advantages in partnering with sponsors and CROs

Orlando, FL (PRWEB) February 16, 2010 -- Akaza Research is pleased to announce its participation in the upcoming 2010 Partnerships in Clinical Trials conference, April 12-14 in Orlando, Florida. The event is being held at the Orlando World Center Marriott Resort and is one of the premier worldwide events for clinical outsourcing and development.

At the event Akaza will be hosting an exhibit booth and presenting OpenClinica, its popular open source electronic data capture and clinical data management software. As the world’s most widely used open source EDC system, OpenClinica offers clinical trial sponsors and Contract Research Organizations (CROs) a uniquely flexible way to obtain an industrial strength electronic data capture system with the benefits of a professional open source model.

“Especially when it comes to partnerships, open source offers real advantages that just don’t exist in the proprietary world,” said Benjamin Baumann, Director of Business Development at Akaza Research, LLC. “For example, a CRO can exercise a much greater degree of control over how its EDC technology is implemented and serviced, delivering greater success to the customer and enabling greater cost efficiency.”

The professional open source model Akaza practices with OpenClinica is similar to that of other notable open source companies such RedHat, MySQL, and SugarCRM.

OpenClinica representatives will be available for discussions at Booth #363.

About OpenClinica®

OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical data management (CDM). OpenClinica facilitates study protocol configuration, data collection via electronic case report forms (eCRFs), and enables productive clinical trials management. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulator guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. All versions of OpenClinica are available for free download from http://www.openclinica.org.

About Akaza Research®

Akaza Research, the leading provider of open source clinical trial software, is headquartered in Waltham, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the he world’s most popular open source clinical research software. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for all types of clinical research. Akaza Research provides OpenClinica support, training, hosting and other value added services to its customers worldwide. See www.akazaresearch.com.

###

Read the full story at http://www.prweb.com/releases/2010/02/prweb3609044.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Akaza Research to Present OpenClinica 3.0 at Upcoming Clinical Research Conferences: SoCRA, SCDM
2. Akaza Research to Present and Exhibit at Upcoming DIA Annual Meeting
3. Akaza Research to Present OpenClinica at ACRP Global Conference & Exhibition
4. Akaza Research Releases New Version of OpenClinica Electronic Data Capture (EDC) Software; Targets Industry Clinical Trials
5. 3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics
6. Dramatic changes in agriculture needed as world warms and grows, researchers say
7. NIH Director Francis Collins to Speak at National Press Club February 26 on A New Era of Quantum Leaps in Biomedical Research
8. European research initiative EUREKA presented at Research & Technology for the first time
9. endpoint Saves Money and Time for Medical Research Teams Through PULSE
10. Peoria Clinical Research Center Tests Investigational Drug to Treat Painful Menstrual Cramps
11. Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Akaza Research to Present OpenClinica Electronic Data Capture Software at Partnerships in Clinical Trials 2010 
(Date:5/23/2016)... Oxitec CEO Hadyn Parry will testify ... before the United States House Committee on Science, Space and ... controlling the spread of the Aedes aegypti mosquito, ... (Logo: http://photos.prnewswire.com/prnh/20150630/227348 ) Oxitec has pioneered ... in Brazil , Panama ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... molecular nanotechnology, announced the winners for the 2015 Foresight Institute Feynman Prizes. ... given in two categories, one for experiment and the other for theory in ...
(Date:5/20/2016)... ... 20, 2016 , ... Kablooe Design, a leading provider of product design and ... anniversary of the business. “We have worked hard to build long-term relationships,” says President ... privilege and honor of serving their product design and development needs through the years.” ...
(Date:5/19/2016)... ... May 19, 2016 , ... Anton Paar USA, located in ... office building is complete. The new structure adds a third office building to the ... USA purchased 2.4 acres of land, along with office space adjacent to the ...
Breaking Biology Technology:
(Date:3/15/2016)... 15, 2016 Yissum Research Development Company ... company of the Hebrew University, announced today the formation ... technology of various human biological indicators. Neteera Technologies has ... from private investors. ... detection of electromagnetic emissions from sweat ducts, enables reliable ...
(Date:3/10/2016)... India , March 10, 2016 ... a new market research report "Identity and Access Management ... & Audit, Compliance, and Governance), by Organization Size, by ... to 2020", published by MarketsandMarkets, The market is estimated ... USD 12.78 Billion by 2020, at a Compound Annual ...
(Date:3/8/2016)... March 8, 2016   Valencell , the ... announced it has secured $11M in Series D ... a new venture fund being launched by UAE-based ... from existing investors TDF Ventures and WSJ Joshua ... continue its triple-digit growth and accelerate its pioneering ...
Breaking Biology News(10 mins):